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ABSTRACT Grove et al. have demonstrated L-type Ca2" channel activity of a synthetic channel peptide (SCP) composed
of four helices (sequence: DPWNVFDFLI10VIGSIIDVIL20SE) tethered by their C-termini to a nanopeptide template. We sought
to obtain the optimal conformations of SCP and locate the binding sites for Ca2+ and for the dihydropyridine ligand nifedipine.
Eight Ca2+ ions were added to neutralize the 16 acidic residues in the helices. Eight patterns of the salt bridges between Ca2+
ions and pairs of the acidic residues were calculated by the Monte Carlo-with-energy-minimization (MCM) protocol. In the
energetically optimal conformation, two Ca2+ ions were bound to Asp-1 residues at the intracellular side of SCP, and six Ca2+
ions were arrayed in two files at the diametrically opposite sides of the pore, implying a Ca2+ relay mechanism. Nine modes
of nifedipine binding to SCP were simulated by the MCM calculations. In the energetically optimal mode, the ligand fits snugly
in the pore. The complex is stabilized by Ca2+ bound between two Asp-1 7 residues and hydrophilic groups of the ligand. The
latter substitute water molecules adjacent to Ca2+ in the ligand-free pore and thus do not obstruct Ca2+ relay. The
ligand-binding site is proximal to a hydrophobic bracelet of lIe-10 residues whose rotation is sterically hindered. In some
conformations, the bracelet is narrow enough to block the permeation of the hydrated Ca2+ ions. The bracelet may thus act
as a "gate" in SCP. Nifedipine and (R)-Bay K 8644, which act as blockers of the SCP, extend a side-chain hydrophobic moiety
toward the lie-10 residues. This would stabilize the pore-closing conformation of the gate. In contrast, the channel activator
(S)-Bay K 8644 exposes a hydrophilic moiety toward the lIe-10 residues, thus destabilizing the pore-closing conformation of
the gate.
INTRODUCTION
Ca2+ channels modulate the movement of Ca2+ in excitable
cells. In spite of intensive study, the molecular mechanisms
of ion selectivity and pharmacological sensitivity of Ca2+
channels are unclear. This is mainly due to the lack of
structural information on these channels. Such information
is necessary to understand the general principles of the Ca21
channels' organization, a goal important for basic knowl-
edge and medicinal applications. By their physiological
characteristics, Ca2+ channels are divided into T-, L-, N-,
and P-types. The L-type Ca2+ channels that mediate the
inward movement of Ca2+ in cardiac and smooth muscle
cells are the best characterized among the four types of the
Ca2+ channels. The L-type channel is composed of five
subunits, a,, a2, f3, y, and 6. The pore is formed by the
a,-subunit, the other subunits having a regulatory role. The
a,-subunit incorporates four domains, I-IV. The folding
pattern of each domain was predicted to comprise six mem-
brane-spanning segments (S1-S6) and two short segments
SS1 and SS2 in the S5-S6 linker, which span the membrane
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only partially. The a,-subunit incorporates receptors for the
well-known Ca2+ channel ligands: phenylalkylamines, ben-
zothiazepines, and 4-aryl-1,4-dihydropyridines. Some of
these ligands are used as drugs for the treatment of cardio-
vascular diseases. In spite of a large body of information on
these drugs, the molecular mechanism of their action at the
Ca2+ channels remains unknown. In particular, the intrigu-
ing fact that the (R)-enantiomer of the dihydropyridine, Bay
K 8644, decreases the open state probability of the L-type
Ca2+ channel whereas the (S)-enantiomer increases it re-
mains to be explained.
Earlier we hypothesized that Ca2+ channels may form
ternary complexes with Ca2+ and the ligands (Zhorov and
Govyrin, 1984, 1985; Ananthanarayanan, 1991a,b). Recent
data show that the Ca2+ channel ligands verapamil, dilti-
azem, nicardipine, and nifedipine bind Ca2+ in a nonpolar
lipid-mimicking environment (Ananthanarayanan et al.,
1992, 1993; Tetreault and Ananthanarayanan, 1993; Bel-
ciug and Ananthanarayanan, 1994). The fact that phenylal-
kylamines and benzothiazepines incorporate amino groups
that are predominantly protonated at physiological pH com-
plies with the possibility of their binding inside the cation-
selective pore of the L-type channel. Contrarily, dihydropy-
ridines (DHPs) that are predominantly in a neutral form at
physiological pH were speculated to bind at the channel-
lipid interface (Kokubun et al., 1986) to the basic amino
acids of the voltage sensor (Langs et al., 1990) at the
cytoplasmic domain adjacent to IVS6 (Regulla et al., 1991).
However, recent experiments suggest that DHP receptor is
located either close to the extracellular entry of the pore
(Kass et al., 1991; Strubing et al., 1993; Tang et al., 1993)
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or inside the pore (Kalasz et al., 1993). DHPs bind to their
receptor in a Ca2+-dependent way (Glossman and Ferry,
1983; Gould et al., 1984; Flockerzi et al., 1986; Knaus et al.,
1992). However, the structural interpretation of these ex-
periments for a complex protein with unknown three-di-
mensional structure is problematic. Studies using simpler
synthetic analogs of the channel are therefore desirable.
Grove et al. (1991) designed a synthetic calcium channel
peptide (SCP) composed of four a-helical segments,
each having the sequence found in the IVS3 transmem-
brane segment of the cardiac L-type Ca21 channel:
DPWNVFDFLI10VIGSIIDVIL20SE (Mikami et al., 1989).
The four helices were tethered by their carboxy termini to a
nanopeptide template: KKKPGKEKG. The authors demon-
strated that the effects of the (S)- and (R)-enantiomers of
Bay K 8644 as well as some other drugs and metal ions at
SCP are similar to those at the L-type channel (Grove et al.,
1991, 1993). In the absence of the basic amino acids in the
transmembrane segments, ionized Asp and Glu residues are
the most probable candidates in SCP to interact with DHPs
and Ca2+ in the ternary complex. Other interactions may
include hydrogen bonding of DHPs to the channel directly
or via water molecules. Hydrophilic residues of the SCP
should face the interior of the pore to constitute a path for
the permeating Ca2 . On the other hand, the exposure of the
hydrophilic residues of the four-helix bundle to the lipid
bilayer will be energetically unfavorable. The DHPs would
therefore be bound inside the hydrophilic pore of the four-
helix bundle. The puzzling question is why DHPs bound
inside the narrow pore do not block it but modulate (in-
crease or decrease) the probability of the channel's closed
state. Molecular modeling is an appropriate approach to
answering this question.
Because SCP is much smaller than the al-subunit of the
L-type channel and has a relatively well-defined four-helix
bundle topology, computer simulation of the former is fea-
sible. In this work, molecular modeling was applied to find
the optimal conformations of the SCP with Ca2+ ions, to
locate the binding sites for the DHP ligand nifedipine inside
the pore, and to estimate the energies of different modes of
nifedipine binding. The results obtained predict the detailed
structure of the four-helix bundle and suggest a mechanism
for the selectivity of the channel to Ca2+ ions versus mono-
valent cations. They also demonstrate the ternary associa-
tion of SCP with nifedipine and Ca2+ and present an ex-
planation for the opposite effects of the (R)- and (S)-
enantiomers of Bay K 8644 on the channel. Because SCP
lacks the short segments SS1-SS2, the critical pore-forming
elements of the authentic voltage-gated ion channels (Guy
and Conti, 1990), the model of SCP is not expected to
predict the detailed structure of the L-type Ca2+ channel
pore. However, the proposed elementary mechanisms of ion
permeation, ion selectivity, and pharmacological sensitivity
of SCP may also be relevant to L-type Ca2+ channels.
Preliminary results of this study have been published as an
MATERIALS AND METHODS
An ECEPP/2 force field (Momany et al., 1975; Nemethy et al., 1983) was
used for calculations of the SCP and its complexes with Ca2' and nife-
dipine. Electrostatic interactions were calculated with a distance-dependent
dielectric (e = r). In the absence of parameters for Ca21 in the ECEPP/2
force field, Ca2' was modeled as an oxygen atom with a double proton
charge (Zhorov, 1993; Zhorov and Ananthanarayanan, 1994). The inter-
actions between Ca21 ions, between Ca21 ions and carboxylate groups,
and between carboxylate groups were calculated at all of the distances.
Other interactions were calculated with a cut-off distance of 7 A. Energy
calculations were carried out on the Indigo-2 Extreme workstation (Silicon
Graphics) using the ZMM package (Zhorov, 1981, 1993). Energy was
minimized in the space of generalized coordinates. The latter were cate-
gorized in two groups: the essential generalized coordinates (torsional
angles specifying rotations of nonsymmetric groups, Cartesian coordinates
specifying translations of Ca21 ions and of the ligand, Euler angles
specifying rotations of the ligand) and nonessential generalized coordinates
(the torsions of the following symmetric groups: CH3, COO, NH2, NO2,
and C6H5). Bond lengths, bond angles, and aromatic rings were kept rigid.
In the transmembrane segments, all backbone torsions, except those of
Asp- 1, were fixed in a preliminarily calculated a-helical conformation (see
Results). It should be noted, however, that the torsions of the template
nanopeptide, including side-chain torsions of Lys residues linking the
nanopeptide to the transmembrane helices, were varied in the search for the
optimal conformations, thus allowing variance of the spatial disposition of
the helices relative to each other and relative to the nanopeptide template.
Proline rings of the transmembrane segments were fixed in trans-down
conformation (Momany et al., 1975). Structures were visualized using the
Insight II (Biosym Inc.) package.
In the SCP molecule, the transmembrane segments connected to the
Lys-l, Lys-3, Lys-6, and Lys-8 residues of the nanopeptide template
KKKPGKEKG were designated Hi, H2, H3, and H4, respectively. Four
levels (A, B, C, and D) normal to the main axis of the four-helix bundle
have been identified to contain, respectively, Glu-22, Asp-17, Asp-7, and
Asp-I (Fig. 1).
The Monte Carlo-with-energy-minimization (MCM) protocol (Li and
Scheraga, 1988) was used for searching the optimal conformations. A
K3 Kl NH
L C~~OOH
H2-A
A
D17
D17 D17
HI
H3 D7
D7 D~~7
NH2
NHd NH2 1H4
FIGURE 1 A sketch of the four-helical bundle of the SCP. The helices
HI, H2, H3, H4 are tethered to Lys residues in the template nanopeptide.
The template and the N-termini of the transmembrane segments are shown
in thick lines. The planes A, B, C, and D indicate the levels of the acidic
residues Glu-22, Asp-17, Asp-7, and Asp-i, respectively. The amino acid
abstract (Zhorov and Ananthanarayanan, 1995).
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recent description of the method may be found in the study of Abagyan and
Argos (1992). Trajectories were calculated at T = 600 K. An initial
structure of a trajectory was usually constructed with the help of the
graphical interface. Then the structure was imported in the ZMM program
and energy was minimized until either the norm of the energy gradient
become less than I kcalmol- 'rad- or the number of iterations exceeded
1000. A subsequent starting point in the trajectory was obtained by chang-
ing a randomly selected essential generalized coordinate G of the preceding
point by a random increment D, where D E (- 180°, 180°) if G was a
torsional angle of the side-chain group or an Euler angle of the ligand, D
E (-60°, 60°) if G was a torsional angle in the template backbone or in a
chain tethering the transmembrane segments to the template, and D E (-4
A, 4 A) if G was a Cartesian coordinate of Ca2+ or the ligand. From a given
starting point, energy was minimized and the resulting minimum-energy
conformation (MEC) was accepted in the trajectory if its energy E was less
than that of the preceding point of the trajectory Ep, or, if a random number
n E (0, 1) was less than exp(-(E- Ep)/R).
In some cases, distances r between specified atoms were restrained
within the boundaries d, < r < dh by using the quasiparabolic function Er
= s(r) * ftr), where s(r) is a switching operator (Brooks et al., 1985):
1
energy MECs found in each trajectory were accumulated in stacks (Zhorov
and Ananthanarayanan, 1993). The stacks were used later for the search of
the MECs meeting specified criteria, e.g., the distances between Ile-10
residues in different helices.
The convergence of a typical restrained MCM trajectory is shown in
Fig. 2 in terms of the energy of the lowest MEC found during simulation
as a function of the number of energy minimizations. The first MEC had
a very high energy, indicating that bad contacts unavoidable in the starting
conformation were not eliminated by a single energy minimization (the
conformation was trapped in a high-energy region of the hyperspace). The
next few hundred energy minimizations steadily decreased the energy,
eliminating step by step the bad contacts. Further minimizations decreased
the energy slowly and increased the number of the collected low-energy
MECs. MCM trajectories were usually terminated when several hundred
additional energy minimizations did not lower the energy of the current
lowest MEC. Different trajectories had a similar tendency of convergence,
the energy of the lowest MEC in the trajectory rarely decreasing after 1000
minimizations at the flat part of the trajectory. The acceptance ratio in the
MCM simulations was 10-20%. Test calculations demonstrated that en-
ergy may further decrease, but not significantly. If a trajectory converged
if r ' d1-x
[(d, + x
-r)2(di + x - 3(d, - x) + 2r)]I(2x)3
s(r)= 0°
[(dh X- r)2(x- dh+ 3(dh+ x) 2r)]l(2x)3
1
if d,-x < r ' di + x
if dl+x < r. dh-x
if dh- x < r. dh±+x
if dh±x < r,
and the penalty function
f(r) = C(r - dh/2 -d/2)2,
where x is the switching distance (0.2 A) and C is the force constant (100
kcal mol- A-2). The restraints were used to impose salt bridges between
Ca21 ions and oxygen atoms (d, = 2 A, dh = 3 A) and to retain the
four-helix bundle topology of the SCP by limiting the distances between
the C3 atoms of Trp-3 residues in the diagonally oppositely spaced helices
(di = 9 A, dh = 11 A). In the simulations of the ligand binding to SCP, the
optimal MECs found in the restrained MCM trajectories were used as the
starting points for the subsequent nonrestrained MCM trajectories. Low-
FIGURE 2 Convergence of a typical MCM trajectory
of SCP. The energy of the current lowest MEC detected
in the trajectory is shown as a function of number of
energy minimizations.
0
-
'U
-
c)
slowly and the energy remained high, this indicated that the specified
restraints were inconsistent with the structure of the SCP. Such trajectories
were terminated after a few hundred energy minimizations. Thus, an MCM
trajectory yields an "almost" lowest MEC in the vicinity of the starting
point but does not move the structure of the macromolecule in a region
essentially different from the starting point (unlike MCM simulations of
oligopeptides, which do). Different regions in the hyperspace of the SCP
seem to be separated by large barriers, overcoming which requires the
simultaneous readjustment of many contacts between helices and, hence,
the variation of many generalized coordinates. A starting conformation in
any step of the MCM trajectory may differ dramatically from the MEC
Minimization
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accepted in the proceeding step (e.g., a change of a torsion in the template
nanopeptide may essentially move a helix). The subsequent single energy
minimization may eliminate bad contacts, but it cannot establish an optimal
set of new contacts between the side chains of the helices, resulting in
MECs with relatively high energy. In the protocol used, such high-energy
MECs were not accepted into the trajectory. This is the reason for the
relatively low acceptance ratio. The main advantage of the protocol used is
that even very bad starting conformations converged reliably to the low-
energy MECs.
RESULTS AND DISCUSSION
Structure of SCP
In light of the available data on many synthetic and natural
peptides that form ionic channels, we assumed a four-helix
bundle conformation for SCP and treated each of the four
transmembrane segments as adopting the a-helix structure.
The optimal side-chain conformations of an isolated helical
segment in SCP were calculated with neutral Asp and Glu
residues, assuming that the charge at the ionized residues
would be compensated by counter-ions. At the starting point
of the MCM trajectory, the main chain torsions were as-
signed a-helical values and the side-chain torsions were
assigned values optimal for the a-helical conformations of
the corresponding model peptides: N-acetyl-X-N-methyl-
amide (X = amino acid). The conformational properties of
the model peptides calculated using the ZMM package were
very similar to those reported by Vasquez et al. (1983)
(Zhorov, unpublished data). In the subsequent starting
points, the side-chain torsions were randomly sampled and
the energy was minimized with both side-chain and main-
chain torsions varied. If during energy minimization the
a-helical conformation of the main chain was disrupted, the
corresponding point was not accepted into the trajectory. In
the lowest energy MEC, the isolated transmembrane seg-
ment of SCP had an a-helical structure slightly bent at the
level of Gly-13. In further calculations of the channel pep-
tide, main-chain torsions of the four transmembrane seg-
ments from Pro-2 to Glu-22 were fixed in the above con-
formation. The (3-hairpin initial conformation was used for
the template nanopeptide, as suggested by Grove et al.
(1991).
The four-helix bundle topology
The helical structure of the transmembrane segments was
imposed by fixing the backbone torsional angles. Geomet-
rical restraints were then used to create different models of
the SCP interacting with Ca2+ ions and nifedipine. The
energetically optimal models were verified later without
restraints. Two types of the restraints were used. The re-
straints of the first type imposed the ionizable acidic resi-
dues to face the pore. These residues are the evident can-
didates to interact with the permeating Ca2+ ions inside the
pore, whereas their contacts with the lipid bilayer would be
unfavorable. An a-helical wheel representation of the trans-
membrane segment (Fig. 3) showed residues Asp-7, Asp-
FIGURE 3 Top and side views of one of the a-helical transmembrane
segments of SCP (the side-chain conformations correspond to those found
in the MEC P1; see text). The polar, hydrophobic, aromatic, and Gly-14
residues are shown, respectively, in red, white, blue, and light green. In the
a-helical wheel diagram superimposed over the top view (left), the residue
designations are positioned at the extensions of the lines drawn from the
helix axis via the corresponding side chains. Polar residues are grouped in
the hydrophilic 900 sector and constitute a pathway for Ca21 permeation.
The hydrophilic sector is also faced by the hydrophobic residues Ile- IO and
Val-18. The remaining 2700 sector is hydrophobic with only one hydro-
philic residue, Asn-4. The residue Asp-I following the helix-braking
residue Pro-2 is not considered a part of the a-helical structure. Note that
C3 atom of the Trp-3 residue is approximately in the middle of the
hydrophilic sector.
17, and Glu-22 falling in a relatively short arc with the C1
atom of Trp-3 residue approximately representing the center
of the arc. The distances between the C0 atoms of Trp-3
residue in the diagonally spaced helices were restrained
within the boundaries of 9-11 A. The minimal number of
the restraints and their relatively wide boundaries helped
compromise the intrapore orientation of the acidic residues
with interactions opposing this orientation.
Interaction of SCP with Ca2+ ions: the
zero-net-charge model
The SCP incorporates 24 ionizable groups: 16 acidic resi-
dues, four basic groups (N-termini) in the transmembrane
segments, and four ionizable groups in the nanopeptide
template (Lys-2, -Glu-7, N-, and C-termini). Because the
ionizable groups in the template as well as in the N-termini
of the transmembrane segments are common for both DHP-
sensitive and non-DHP-sensitive peptides (Grove et al.,
1993), they are not expected to be involved in interactions
with the ligand. Therefore, these groups were treated as
neutral, implying that their charges will be compensated by
the counter-ions of the extra- and intracellular environment.
The acidic groups in the transmembrane fragments that may
directly interact with the permeating Ca2+ were considered
in their ionized forms. Evidently at least some of the neg-
ative charges of these groups should be compensated by the
permeating cations. The number of Ca2+ ions in the pore is
Zhorov and Ananthanarayanan 25
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not known. We assumed that the pore incorporates eight
Ca2+ ions, which would make the system electrically neu-
tral (the zero-net-charge model).
The zero-net-charge model is less arbitrary than models
with non-ionized or partially ionized acidic residues, be-
cause the mutual compensation of the positive and negative
charges in a macromolecule and its immediate environment
is energetically the most favorable situation. Alternative
models would require additional assumptions of either a low
pH inside the pore or the compensation of the charges at the
ionized residues by implicit counter-ions. Both assumptions
are weak: at physiological (millimolar) concentration of
Ca2+ in the extracellular solution, pH inside the Ca2'
channel pore should be higher than in the bulk solution (see
below), and the explicit consideration of Ca2+ ions, the
natural occupants of Ca2+ channels, is more realistic than
implicit consideration of nonspecified counter-ions. The
accurate calculation of ion-ion interactions by the molecular
mechanics method is problematic. Because ion-ion interac-
tions in the zero-net-charge model would compensate each
other, the calculations of this model would be more accurate
than calculations of non-zero-net-charge models. Even if
the real number of Ca2+ ions simultaneously bound to SCP
is less than eight, the zero-net-charge model may be con-
sidered as a snapshot obtained with an exposure time of the
few microseconds necessary for the permeation of a few
Ca2+ ions. In such a snapshot, all of the potential binding
sites for Ca2+ would be occupied. A last and important
argument in favor of the zero-net-charge model is that it
explains the electrophysiological and pharmacological
properties of SCP, as will be shown subsequently.
Salt bridges between Ca2+ ions and SCP
Electrostatic interactions should maximize the number of
salt bridges involving Ca2+ and any two of the acidic
residues of the SCP. Because the number and mobility of
water molecules inside the narrow four-helix bundle pore
are limited, such bridges should be relatively stable. The
four-helix bundle topology limits the number of the possible
salt bridges. The CI atoms of Asp-17 and Asp-7 in the same
helix are separated by 16.2 A, which excludes intrahelical
salt bridges between levels B and C (Fig. 1). Interhelical salt
bridges B-C as well as any salt bridges A-C, A-D, B-D
would be even longer and, hence, are also excluded. The C1
atoms of Glu-22 and Asp-17 within a given helix are sep-
arated by 9.5 A, permitting the formation of salt bridges
between levels A and B. The bridges A-A, A-B, and B-B
may be represented by patterns connecting eight vertices of
a parallelepiped by four noncrossing lines; crossing lines
would correspond to the bridges with two Ca2+ ions in
nonrealistically close proximity. Patterns with the diagonal
lines running through the pore axis would interfere with the
intrapore binding of DHP ligand. This leaves eight primary
patterns of salt bridges (Fig. 4). A number of symmetrical
patterns may be obtained by rotating the primary patterns
P1 P2 P3 P4
P5 P6 P7 P8
FIGURE 4 Eight conceivable patterns of salt bridges between Ca21 ions
and pairs of acidic residues of SCP. The top and bottom planes of the
parallelepipeds represent levels A and B of the four-helix bundle, respec-
tively (see Fig. 1). The vertical ribs of the parallelepipeds represent the
helices HI to H4 (shown anticlockwise from top right). The thick lines
indicate the salt bridges.
around the vertical axis by 900, 1800, or 2700. Because the
helices are homologous, their rotation around the template-
helix chains would accomplish the same helix-helix inter-
actions in a primary pattern and in the patterns symmetric to
it. The nanopeptide template would have different orienta-
tions relative to the salt bridges in the primary and symmet-
ric patterns. However, the backbone of the template is
remote from the salt bridges and should not strongly affect
their stability. The above reasoning led us to consider the
primary patterns only.
At level D, Asp-I residues terminate the transmembrane
segments following the helix-braking Pro-2 residues. There-
fore, the main-chain conformation of Asp-I is indefinite
(the torsion angles 4' in Asp-I residues were sampled in
MCM trajectories; see Materials and Methods). In spite of
the conformational flexibility of Asp- 1 residues, salt bridges
between levels C and D are not possible: inside the pore
they would be sterically hindered by the bulky Trp-3 resi-
dues, and outside the pore they would expose Ca2+ to the
lipid environment. Thus, Asp-7 and Asp-i residues may be
involved in intralevel bridges only. Because the intracellular
water environment would destabilize electrostatic interac-
tions between Ca2+ and Asp-I residues, these interactions
seem to be more important for "delivering" Ca2+ from the
pore into the cell rather than for the stabilization of the SCP
conformations. Therefore, no restraints between Asp-I res-
idues and Ca2+ ions were imposed. At level C, only two salt
bridges may be formed simultaneously, half the number at
the levels A-B. Hence, the bridges at level C would be less
important in stabilizing the conformations of the channel.
No restraints between Asp-7 residues and Ca2+ ions were
therefore imposed, implying that the formation of the salt
bridges at level C would comply with the salt bridges
imposed by the restraints at levels A and B. In the starting
conformation of each MCM trajectory, a pair of Ca2+ ions
were placed in the vicinity of the carboxylate groups at both
levels C and D. The locations of these ions were optimized
during the MCM calculations.
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Optimal conformation of the complex of SCP
with Ca2+ ions
The eight primary patterns specifying salt bridges at levels
A and B were evaluated in the eight restrained MCM
trajectories (Table 1). The final (lowest) MECs found in the
trajectories are designated by the names of the correspond-
ing patterns (e.g., P1 in Fig. 4). The restraints specifying salt
bridges were met in almost all of the final MECs. An
exception was found in the MEC P6, in which some of the
restrained distances for Ca2+-O were 4-5 A, exceeding the
set limit by 1-2 A (see Materials and Methods). Hence,
pattern P6 is not consistent with the four-helix bundle
topology of the SCP. The high energies of the MECs P2, P4,
P6, P7, and P8 indicate poor consistency of the correspond-
ing patterns with the four-helix bundle topology of the SCP.
The MECs P1 and P3 are energetically much more prefer-
able than other MECs. These two MECs are essentially
different: MEC P1 corresponds to a wide pore, with room
for a number of water molecules to neighbor each chelated
Ca2+ ion, whereas the helices in the MEC P3 are tightly
packed (Fig. 5). Between the two low-energy MECs P1 and
P3 we chose the former, as it corresponded to a structure of
SCP that would allow Ca2+ ions to permeate through and
accommodate intrapore binding of DHP ligand as well. The
structure P3 may represent one of the closed conformations
of SCP. The capacity of the pore to adopt essentially dif-
ferent conformations may be the basis for one of the mech-
anisms of SCP gating in the absence of ligands. The crucial
role of Ca2+ in stabilizing these MECs is consistent with the
known Ca2+ requirement for selectivity and gating of ion
channels (Armstrong and Miller, 1990).
In MEC P1, practically all polar residues of the channel
are inside the pore, whereas the exterior is hydrophobic. Six
Ca2+ ions bridge the helices H1-H4 and H2-H3 at the three
levels (Fig. 6). Although only one atom in each of the eight
acidic residues at the levels A and B was restrained to Ca2+
ion in the initial conformation, additional coordinating
TABLE I MCM trajectories of Ca2"-bound SCP calculated
with restraints*
Salt Lowest MEC
bridge No. of energy
patternt minimizations Step§ E,11 kcal/mol Er,' kcal/mol
P1 7463 898 0 <1
P2 3515 2919 315 <1
P3 5400 3937 29 <1
P4 5000 4650 743 50
P5 5122 4481 117 <1
P6 900 900 3231 1986
P7 2900 2881 182 <1
P8 5700 5426 355 <1
*Ca2+1 O and Trp-Trp restraints; see text.
*The patterns are designated as in Fig. 2.
§The number of energy minimization yielding the lowest MEC.
I'Above the lowest MEC P1 (the absolute energy of the MEC P1 is - 1612
kcal/mol).
¶I The energy of the restraints.
FIGURE 5 Lowest-energy MECs of SCP with eight Ca21 ions found in
the MCM trajectories with the restraints imposing the patterns of the salt
bridges P1 (left) and P3 (see Fig. 4 for the sketches of the patterns P1 and
P3 and Table 1 for their energies).
bonds appeared in the subsequent MCM trajectory. Thus, at
level A, one pair of glutamates chelated the first Ca2+ ion
tetradentately and the other pair of glutamates chelated the
second Ca2+ tridentately. At level B, two aspartates che-
lated each Ca2+ ion tridentately. At level C, both Ca2+ ions
were chelated tetradentately by two aspartates. At level D,
salt bridges were not formed, and both Ca2+ ions were
bound to single aspartates. Thus, in MEC P1, Ca2+ ions
were organized in two files situated at diametrically oppo-
site sides of the pore.
The a-helical wheel representation of one of the trans-
membrane segments of the channel in MEC P1 clearly
demonstrates its amphipathic nature (Fig. 3). The acidic
residues Asp-7, Asp-17, and Glu-22 face a 900 sector.
Along with the hydrophilic residues Ser-21 and Ser-14, the
acidic residues may constitute a path for the permeating
Ca2+ ions. The aromatic residues Phe-6 and Trp-3, which
face the hydrophilic sector, would also contribute their
ir-electrons for the interaction with the permeating Ca2+
ions. The remaining 2700 sector of the wheel is hydropho-
bic, having only one hydrophilic residue, Asn-4.
Thus, formation of the salt bridges of the SCP with the
permeating Ca2+ ions may sustain the 3-D structure of the
pore lined up by the acidic residues. No calculations of the
SCP without Ca2+ ions were performed. Such calculations
would yield MECs with the acidic residues distanced from
each other because of repulsion of their negative charges. It
would be difficult to use such structures for the explanation
of the electrophysiological and pharmacological properties
of the SCP.
Asymmetry of Ca2+-bound SCP
As was shown earlier, pairs of Asp-7, Asp-17, and Glu-22
residues in the adjacent helices of SCP sustain each file of
Ca2+ ions. The C0 atom of Asp-17 (at level B) is most
distanced from the median among C3 atoms of the three
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FIGURE 6 Top and side views of the SCP showing Ca2+ chelating patterns at the levels A (yellow), B (red), and C (green). At level A, one pair of
glutamates chelate the first Ca21 ion tetradentately, and the other pair of glutamates chelate the second Ca21 tridentately. At level B, two aspartates (Asp- 17)
chelate each Ca21 ion tridentately. At level C, both Ca21 ions are chelated tetradentately. Note the asymmetric disposition of the acidic residues and Ca21
ions relative to the pore axis. The asymmetry at level B (red) is the main cause of energy dissimilarity among different modes of nifedipine binding.
acidic residues in the same helix (Fig. 3). Asp-17 residues in
the helices HI and H3 are closer to the pore axis than
Asp-17 residues in the helices H2 and H4 (Fig. 6). The side
chains of the Asp- 17 residues fold toward the pore axis to
bring the carboxyl groups into the required proximity nec-
essary to form the salt bridges. However, because the resi-
dues are relatively far from each other, their four oxygen
atoms cannot reach the Ca2+ ion simultaneously and the ion
is chelated only tridentately. Because each Asp-17 residue
in the helices HI and H3 offers a pair of oxygen atoms for
interaction with Ca2 , the cations are attracted closer to the
helices HI and H3 than to the helices H2 and H4. In the
latter two helices, each Asp-17 residue offers only one
oxygen atom for interaction with Ca2+. A pair of Asp-17
residues chelating one ion cannot come any closer to each
other by twisting the helices, because this would be resisted
by the salt bridges at levels A and C. This asymmetry found
in many MECs is, evidently, an intrinsic property of the
SCP. The important consequence of this asymmetry is the
energetic dissimilarity of different modes of nifedipine
binding (see below).
Mechanism of Ca2+ influx and ion selectivity
of the SCP
The arrangements of Ca2+ ions and the acidic residues at
levels A, B, and C have a remarkable common feature: two
Ca2+ ions are chelated by the carboxylate groups at the
diametrically opposites sides of the pore, the center of the
positive charge of each Ca2+ ion being closer to the pore
axis than the centers of the negative charges at any of the
carboxylate groups (Fig. 6). This arrangement has three
important consequences. First, mono- or divalent cations
trying to pass between the two chelated Ca2+ ions would
meet the repulsion from their positive charges, which would
prevail over the attraction by the negative charges of the
carboxylate groups. Monovalent cations at physiological
concentrations could enter the pore and, in principle, satisfy
all of the negative charges. However, two monovalent cat-
ions have to collide simultaneously with Ca2+ to displace it.
Because the probability of such a collision is low, monova-
lent cations have only a low chance of substituting the
chelated Ca2 . Contrarily, a divalent cation approaching the
pore from the extracellular space may substitute any of the
two Ca2+ ions chelated at level A and push it down the pore
because of charge repulsion. This explains the Ca2+ selec-
tivity of the SCP observed in experiments (Grove et al.,
1993). Second, the repulsion between the two Ca2+ ions
chelated at the same level of the pore is only minimally
screened by the carboxylates. This repulsion would promote
Ca2+ dissociation from the glutamates, thus facilitating
Ca2+ permeation along the pore by a relay mechanism.
(Water molecules in the pore would also facilitate Ca2+
movement between the binding sites by lowering the energy
barriers between them due to formation of hydration shells
(Hille, 1992). Third, electrically neutral drugs such as DHPs
may fit the vacant space between the chelated Ca2+ ions and
interact electrostatically with them. This provides for the
possibility of a ternary association between SCP, Ca2+ and
SCP ligands.
The above mechanism preventing monovalent cations to
enter the pore applies also to the hydroxonium ion, the
carrier of protons. Therefore, the local pH inside the pore
should be higher than in the extra- and intracellular solu-
tions implying that the acidic residues (at least at the levels
A, B and C) should be permanently ionized. The ionized
acidic residues would attract Ca2+ ions abundant in the
extracellular space and in the vicinity of the pore. All these
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considerations strongly support the present model in which
Ca2+ ions neutralize the charges of the ionized acidic res-
idues in the pore.
In the absence of Ca2+ ions in the extra- and intracellular
bulk solutions, the cation binding sites in the SCP would be
occupied by the monovalent cations. The electrostatic at-
traction of the monovalent cations to the acidic residues of
the pore would not, however, be as strong as the attraction
of divalent cations. This would explain the fact that in the
absence of divalent cations, SCP has high permeability to
monovalent cations (Grove et al., 1993).
"Gate" of the SCP
The difference in the dimensions of the pore in the confor-
mations P1 and P3 (Fig. 5) may account for SCP gating in
the absence of the ligand. Gating was also demonstrated for
the ligand-bound SCP (Grove et al., 1991). The closed pore
P3 would not accommodate the ligand. Because the lifetime
of the ligand-SCP complex would exceed the lifetimes of
individual open and closed states, there should be additional
mechanisms of SCP gating in the P1 conformation. We
explored this point by considering the hydrated Ca2+ ion.
It is well known that Ca2+ in bulk solution strongly
interacts with water molecules of the first hydration shell. A
possible pattern of Ca2+ coordination by water molecules
was found in the crystal CaBr2 1OH202(CH2)6N4, where
six water molecules lie around the Ca2+ at distances ranging
from 2.32 to 2.35 A (Hille, 1992). We assume that when
Ca2+ enters the pore, at least six water molecules would
accompany the ion. Some of the water molecules may be
substituted by the hydrophilic groups inside the pore. In
addition to the acidic residues Glu-22, Asp-17, and Asp-7,
which face the pore and provide binding sites for Ca2 , the
pore is lined up by the hydrophilic residues Ser-21 and
Ser-14, which may serve as the intermediate binding sites
for Ca2+ ions permeating the pore (Fig. 3).
A loss of even one water molecule from the entourage of
the permeating Ca2+ ion without compensation by an oxy-
gen atom or ir-electrons would be energetically unfavorable
(Hille, 1992). Therefore, in the open channel, the pore at the
levels of all the hydrophobic residues should be wide
enough to accommodate Ca2+ with its entire water entou-
rage. The narrowing of the pore even at one level of the
hydrophobic residues would hinder the ion's passage, im-
plying that the corresponding residues may represent the
closed "gate" of the channel. Each transmembrane segment
incorporates four hydrophobic residues that face or may
face the pore: Val-18, Ile-10, Phe-6, and Trp-3 (Fig. 3).
Trp-3 and Phe-6 residues should not be a decisive obstacle
to Ca2+ permeation because their nT-electrons would at least
partially substitute the water molecules in the entourage of
Ca2+. This suggestion is supported by the fact that muta-
tions of Leu-577 to Trp in the pore-forming M2 transmem-
brane segment of the glutamate receptor increased the per-
meability of the channel to divalent cations by three to four
times (Ferrer-Montiel et al., 1995). The pore at the level of
Val-18 is wide enough to accommodate the Ca21 :(H20)6
complex. Thus, a bracelet of four Ile-10 residues remains
the only candidate to serve the role of the hydrophobic
"gate" in SCP.
The minimal-profile projection of the complex Ca2+:
(H20)6 may serve as a rough criterion to discriminate the
open and closed states of the pore at the levels of hydro-
phobic residues. To obtain such a projection, we calculated
a 1000-step MCM trajectory of the cluster Ca2+:(H20)6 in
vacuo. It yielded the apparent global MEC with the six
water molecules H-bonded to each other at one side of the
Ca2+ sphere (see Fig. 7). The dimensions of the minimal-
profile rectangle (Voitenco et al., 1991) described over the
apparent global MEC of the cluster Ca2+:(H20)6 are 5.5 X
7.9 A. Interestingly, the dimension of the shorter side of the
rectangle (5.5 A) is close to the "diameter" of N(CH3)4+
(about 6 A), the largest organic cation permeable through
the L-type Ca2+ channel (McCleskey and Almers, 1985).
Fig. 7 shows the bracelet of four Ile-10 residues in two
different conformations found among the MECs accumu-
lated in the MCM trajectory P1. In both conformations, the
profile of the pore between the four Ile-10 residues is
roughly congruent to the minimal-profile projection of the
cluster Ca2+:(H20)6. The cluster fits better in one MEC
than in the other. In both MECs, the pore at the level of
Ile-10 residues is not wide enough to let the cluster Ca2+:
(H20)6 pass through. However, the dynamic oscillations of
the channel and the cluster may help the latter to pass; the
probability of passing via the wider MEC is, evidently,
higher. This supports the suggestion that the bracelet of
Ile-10 residues may represent the gate of the SCP. The two
FIGURE 7 Ring of four Ile-10 residues representing the "gate" of the
SCP in the closed (left) and open (right) conformations found in MCM
simulations (see text). The helices HI to H4 are shown anticlockwise from
top right. The energetically optimal conformation of the cluster Ca21:
(H20)6 (see text) fits the open gate better than the closed gate: in contrast
to the open conformation, the methyl group of H1 Ile-10 residue (shown
in light blue) in the closed conformation protrudes into the pore, pushing
the cluster from H4 Ile-10 toward H3 Ile-10 residue. The permeation of
Ca21 via the closed gate would require energetically unfavorable separa-
tion of at least one water from the entourage of the cation.
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MECs transform to each other by rotation of one Ile-10
residue rather than by the movement of the helices. The
lifetimes of the open and closed states of the SCP are in
milliseconds (Grove et al., 1993), implying that the barrier
height between the two states is about 12 kcal/mol. The
barrier for nonhindered rotation around a C-C bond (about
3 kcal/mol) provides nanosecond lifetimes of the conforma-
tions. However, in the optimal conformation of the SCP,
Ile-10 residues of the helices HI and H2 are in close contact
with those in the helices H4 and H3, respectively (Fig. 7).
These contacts hinder the rotation of Ile-10 residues and
would increase the lifetimes of their conformations to the
level compatible with the lifetimes of the open and closed
states of the channel. However, accurate calculation of the
rotational barriers for Ile-10 residues in a model of SCP
with rigid valence geometry is problematic. So, we do not
exclude the possibility that movements of the helices not
observable in the MCM simulations may determine the
lifetimes of the open and closed states. But, even in this
case, the direct interaction of the ligand with the "gate" (see
below) may modulate the stability of their conformations
and hence the probability of the open and closed states.
Structure of SCP with bound nifedipine ligand
Bioactive conformation of nifedipine
The structural formulae of the DHP ligands active at SCP
are shown in Fig. 8. The probable conformation of nifedip-
ine prevailing at the receptor site of an L-type Ca2+ channel
is a flattened-boat DHP ring orthogonal to the plane of a
pseudoaxial 4-aryl group at the "bowsprit" with the polar
group in the bowsprit maximally separated from the NH
group at the stern (Goldmann and Stoltefuss, 1991; Govyrin
and Zhorov, 1994). The substituents at the starboard and
port sides of the DHP ring are flexible and may be involved
in Ca2' binding, as was predicted by Zhorov and Govyrin
(1985) and was shown experimentally for nicardipine by
Belciug and Ananthanarayanan (1994). We have assumed
that the above conformation would prevail for nifedipine in
the pore of SCP. In this conformation, nifedipine has an
overall elongated shape, with the long axis passing via
extended carbomethoxy groups (Fig. 9). Three orientations
of the conformer inside the pore are possible: 1) 4-aryl plane
normal to the pore axis, 2) the plane of the DHP ring normal
to the pore axis, and 3) both DHP ring and 4-aryl planes
parallel to the pore axis. The dimensions of the minimal-
profile rectangles (Voitenco et al., 1991) described over a
wire-frame model of nifedipine (Fig. 9) show that the latter
would fit a pore as small as 6.2 X 8.6 A in the first binding
orientation, whereas the second and the third orientations
would require pore sizes of 8.6 X 11.4 and 6.2 X 11.4 A,
respectively (taking into account van der Waals radii of
atoms along the sides of the rectangles, the actual dimen-
sions of the pore should be 2.4-2.6 A larger). The narrow
pore of the four-helix bundle is likely to accommodate
nifedipine bound in the first orientation only, and hence
further calculations were made using this orientation of the
drug.
Starting conformations for nifedipine docking
The energies of possible complexes of nifedipine with SCP
were obtained by calculating MCM trajectories. Only local
conformational changes in the SCP and nifedipine were
expected during one MCM trajectory. Larger changes such
as flip-flop of the ligand in the pore, rotation of nifedipine
along its long axis, and translation of nifedipine along the
pore would have small probability of being accepted in the
MCM trajectory because such changes would involve rela-
tively high energies for the MECs (see Materials and Meth-
ods). Therefore, different starting conformations were cho-
sen to explore distinctive sites and modes of nifedipine
binding. The pore beneath levels A and B is faced, respec-
tively, by the relatively small Ser-21 and Ser-14 residues,
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FIGURE 9 Bioactive conformation of nifedipine projected at the plane
parallel to the 4-aryl group (left) and at the plane parallel to the DHP ring
(right). The dimensions (in angstroms) of the minimal-profile rectangles
described over the projections are shown. The dimensions of the projection
at the plane perpendicular to both the DHP and 4-aryl rings (not shown) are
6.2 x 11.4 A. Taking into account van der Waals radii of the hydrogen (1.2
A) and oxygen (1.4 A) atoms located against the sides of the rectangles, the
dimensions of the rectangular pores to accommodate the MECs should be
8.8 x 11.2 A, 11.2 X 13.8 A, and 8.8 x 13.8 A, respectively, for the three
projections.
whereas the pore between levels C and D is crowded by the
bulky aromatic residues. Therefore, the sites between levels
A and B (level A-B) and between levels B and C (level B-C)
were considered most promising for the docking experi-
ments. At both sites, two chelated Ca2+ ions protrude into
the pore. Only the shorter side of the elongated rectangle
approximating the minimal profile of nifedipine (Fig. 9)
may fit between Ca2+ ions. Two orientations of the rectan-
gle are possible, with the bottom of the DHP ring facing the
salt bridge between helices H2-H3 in one case and between
helices H1-H4 in the other. In each orientation, two modes
of nifedipine binding are possible, one where the port-side
group points up and another where it points down the pore.
The four types of nifedipine orientations at each of the
levels A-B and B-C make eight possible binding combina-
tions. Therefore, eight independent MCM trajectories were
calculated.
A typical docking was simulated as follows. Using the
graphical interface, nifedipine was placed at a specific level.
The number of bad contacts (overlaps) between the ligand
and the channel was minimized initially by manual adjust-
ments of the ligand. However, it was not possible to remove
all of the bad contacts. Because these contacts could cause
the separation of the helices during minimization, the first
stage of the MCM trajectory was calculated with the re-
straints between diagonally spaced Trp-3 residues. The re-
straints were then removed and the second stage of the
MCM trajectory was carried out.
Complexes of SCP with DHPs
The energies of the lowest MECs found in each trajectory
are given in Table 2. At the level A-B, a few of the
functional groups of the channel were involved in the bind-
ing and two Ca2+ ions were chelated simultaneously by
nifedipine (Fig. 10). However, the bulky Val-18 residues
that partially protrude into the pore caused the ligand bind-
ing at this level to be energetically unfavorable. Nifedipine
binding at the level B-C was more preferable, even though
fewer ligand-channel hydrogen bonds occurred here. The
NH group of nifedipine, important in binding to L-type
channels (Goldmann and Stoltefuss, 1991), was remote
from any proton-acceptor group in the most optimal MEC
TABLE 2 MCM simulations of nifedipine docking to SCP*
Ligand binding mode Lowest MEC Ligand contacts§
Port-side DHP bottom No. of energy Step when Energy,
Level direction direction minimizations it appeared kcal/mol* =Op >Op _=Os NO' NO" NH
I. Binding inside the pore
A-B Up H1-H4 3697 2757 57 Ca2+ Ca2+ Ca2+11 1S21
A-B Up H2-H3 2409 1605 59 Ca2+ 3S2111
A-B Down H1-H4 3142 2582 63 1S21
A-B Down H2-H3 8759 6561 97 1S2111 Ca2+ 4E2211
B-C Up HI-H4 6604 4650 17 4S14 Ca2+ 4S1411 2S141
B-C Up H2-H3 6100 5493 37 Ca2+ 4S1411
B-C Down Hl-H4 9300 5508 26 2S1411 Ca2+ 3D17
B-C Down H2-H3 14000 135461 0 Ca2+
II. Binding outside the pore
B Down H2-H3 16300 13952 9
*The trajectories started from the lowest MECs obtained in the preceding MCM trajectories calculated with Trp-Trp restraints.
tRelative to the lowest MEC found in all the trajectories (the absolute energy of the lowest MEC is -1665 kcal/mol).
tCa2+ ions or SCP groups forming donor-acceptor contacts with the ligand. The subscripts p and s designate port and starboard side-chain groups of
nifedipine, respectively. The prefix before the SCP residue designation stands for the helix number (see Fig. 1).
IlDonor-acceptor contacts are possible via water molecule (the distance between donor-acceptor atoms are 3-4 A).
qThe energy reached -1660 kcal/mol (below levels found in any other trajectory) at the 2245th energy minimization.
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FIGURE 10 SCP with nifedipine bound at the level A-B with the port-
side group pointed up the pore and the bottom of the DHP ring pointed to
the helices H1-H4. Although the ligand coordinates two Ca21 ions, the
complex is energetically unfavorable because of repulsion of the ligand
from Val-18 residues (light blue).
of SCP-nifedipine complex (Table 2). It should be empha-
sized that the present model does not consider water mole-
cules, which should fill the pore. Some of these molecules
may provide additional H-bonds for nifedipine binding. It is
important to note, however, that the most significant con-
tribution to binding energy comes from the ligand-Ca2+
interaction inside the pore rather than from other weaker
noncovalent interactions.
Ligand binding with the port-side group pointing down
the pore and the bowsprit polar group pointing to the Ca2+-
bridged helices H2-H3 at the level B-C turned out to be
most preferable energetically (Fig. 11 C). This is in confor-
mity with the asymmetry of the SCP described earlier. In the
less favorable port-side-up modes of nifedipine binding, the
NO2 group of the ligand approaches Ca2+ from the side of
the more remote helix, pushing the bulky DHP ring into a
less spacious half of the pore interior. This difference in the
port-up and port-down modes of binding is crucial to ex-
plaining the opposite effects of the (R)- and (S)-enantiomers
of Bay K 8644, as will be shown below.
FIGURE 11 Top view of the four modes of nifedipine binding to SCP at
the level B-C. In each mode, helices HI to H4 are shown anticlockwise
from the top right. (A) Nifedipine port-side group points in the extracellular
direction (up the pore), and the bottom of the DHP ring points between the
helices H2-H3. (B) Nifedipine port-side group points up the pore, and the
bottom of the DHP ring points between the helices H1-H4. (C) Nifedipine
port-side group points down and the pore and bottom of the DHP ring
points between the helices H2-H3. (D) Nifedipine port-side group points
down the pore, and the bottom of the DHP ring points between the helices
H1-H4. The energies of the four binding modes are given in Table 2. Only
Ser-14 and Asp-17 residues that may have donor-acceptor interactions with
the ligand either directly or via Ca21 ions or water molecules are shown.
Note that Ca21 ions are located more closely to the helices HI and H3 than
to the helices H2 and H4. This asymmetry may account for the fact that the
port-down modes of nifedipine binding are more preferable energetically
than the port-up modes (see text).
In the energetically preferable mode of binding, nifedip-
ine fits snugly into the pore, as evidenced by the fact that,
after removing the ligand, MCM simulation of the pore
results in only minor changes of the side-chain conforma-
tions. The complex is stabilized by Ca2+ ion bound between
two Asp-17 residues and the hydrophilic group of the ligand
(Fig. 12). The latter could substitute water molecules adja-
cent to Ca2+ in the ligand-free pore and thus would not
obstruct Ca2+ movement along these hydrophilic groups.
The level of the pore critical for Ca2+ permeation is at the
interface between DHP and the "gate" of SCP. The chem-
ical structure of the DHP group abutting the gate may thus
control the ion permeation (see below).
A few other MCM trajectories were calculated to esti-
mate the relative stability of the optimal structure. Transla-
tion of nifedipine in the membrane plane 30 A from the pore
axis yielded a structure with an energy of 60 kcal/mol above
the lowest MEC found in the trajectories (the "best" MEC).
This demonstrates that binding of nifedipine to the four-
helix bundle is energetically preferable. Another MCM tra-
jectory started from a structure with nifedipine bound out-
side the pore and yielded an optimal structure with the CH3,
NH, and C=O groups of the ligand deeply penetrating the
interface between helices H2-H3 and the C==O group ap-
proaching the intrapore-bound Ca2+. However, the energy
of this conformation was 9 kcal/mol above the best MEC
(Table 2), demonstrating that intrapore binding of the ligand
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FIGURE 13 Space-filling views of the synthetic calcium channel with
nifedipine (shown in purple) in the optimal mode of binding. The pore is
accessible for the ligand from the interface between the helices H1-H2 and
H3-H4 exposed to the lipid bilayer but not accessible from either the top or
the bottom openings of the channel.
FIGURE 12 Top and side views of the SCP with nifedipine bound at the
level B-C with its port-side residue pointed down the pore and the bottom
of the DHP ring pointed to the helices H2-H3. The ligand's polar groups,
which coordinate Ca2 , would not hinder the passage of the ion via
corresponding level of the pore compared to the ligand-free pore filled with
water molecules. The level of the pore critical for Ca21 permeation is at the
interface between the DHP port-side group and the "gate" of Ile-10
residues (whose van der Waals spheres are shown in light blue). The
methyl moiety in the port-side group of nifedipine approaches the "gate"
and may stabilize its closed conformation.
is preferable to extrapore binding. Because our calculations
ignore effects of environment, entropy, and other factors,
the computed energy difference may not be useful for
estimating the probabilities of intrapore versus extrapore
binding. However, the calculations do demonstrate the steri-
cal and energetic possibility of intrapore binding. A much
stronger argument in favor of intrapore binding is that it
explains structure-activity relationships of DHPs (see be-
low).
An attempt to insert the ligand at level C failed as the
ligand was pushed out of the pore. Space-filling displays of
the optimal structure (Fig. 13) show that although the pore
is not accessible for nifedipine ligand from the sides ex-
posed to extra- and intracellular solutions, it is accessible
from the side exposed to the lipid bilayer. This indicates that
the binding of nifedipine inside SCP is possible not only
thermodynamically but also kinetically.
We also carried out simulations of the binding of (R)- and
(S)-Bay K 8644 to SCP to illustrate the important difference
between a blocker and an activator. In these calculations,
the optimal mode of the nifedipine-SCP complex was used
as the starting point. In the absence of parameters for the
fluorine atom in the ECEPP/2 force field, hydrogen atoms
were used to calculate van der Waals interaction of the
fluorine atoms with other atoms. Because the CF3 and NO2
groups of Bay K 8644 are not larger than the corresponding
substituents in nifedipine, the starting points of the trajec-
tories had low energy. The trajectories converged rapidly,
the ligands moving slightly to provide close contact be-
tween their CF3 groups and Ca2+ (Fig. 14).
Possible mechanism of SCP gating modulation by DHPs
DHP ligands do not affect the amplitude of the Ca2+ current
in SCP, but alter the open state probability (Grove et al.,
1993). The passage via gate cannot be a rate-limiting step
for Ca2+ permeation for the following reason. If the gate is
open, water molecules would rearrange around Ca2+ to
adopt a conformation congruent to the space between the Ile
residues (lumen). Because such a rearrangement does not
require separation of Ca2+ and water molecules, the energy
barriers would be small (say, 3 kcal/mol) and the time for
the rearrangement would be in nanoseconds. If the gate is
closed, the cluster would have to shed a water molecule.
This is costly (>15 kcal/mol; Hille, 1992), and the ion
passage will require about a second. In reality, Ca2+ per-
meates SCP in microseconds (Grove et al., 1993). The
barrier for this should only be about 7- 8 kcalmol. Cleavage
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FIGURE 14 Side views of the SCP with the bound blocker (R)-Bay K 8644 (left) and activator (S)-Bay K 8644 (right). The (R)-isomer extends its
hydrophobic port-side group to the "gate" and may stabilize its closed conformation. The (S)-isomer has only a short hydrophilic residue that does not plug
the "gate" and hence stabilizes the open conformation of the pore (see text).
of bonds between Ca2+ and carboxylates (accompanied
with their substitution by water molecules) may easily ac-
count for such a barrier. Because glutamates are longer and
more flexible than aspartates, they would hold Ca2+ more
tightly. Therefore, the dissociation from glutamates may be
the rate-limiting step for the permeation.
Both blockers and activators bound inside the pore would
stabilize its "wide-pore" conformation P1 and exclude the
transition of SCP to the "flattened-pore" conformation P3,
which is not permeable to hydrated Ca2+ ions (Fig. 5).
However, this cannot explain the gating of the ligand-bound
SCP observed by Grove et al. (1991). A basis for the gating
may be the hindered rotation of Ile-10 residues, whose open
and closed state probabilities may be modulated by the
ligand group adjacent to them. In any of the four modes of
binding at level B-C, the SCP blocker nifedipine exposes a
hydrophobic side-chain group toward the Ile bracelet (Fig.
12). The latter would occlude the space between the Ile
residues and stabilize the closed conformation of the gate
due to Van der Waals and hydrophobic interactions. Inter-
estingly, conformations with both open and closed gates
(Fig. 7) were accumulated in MCM simulations of nonli-
ganded channel as well as in the MCM simulations of
nifedipine bound at level A-B inside and outside the pore.
However, only conformations with the closed gate were
found in a long MCM trajectory simulating nifedipine
bound inside the pore between levels B-C.
Our model of SCP also accounts for the opposite effects
of enantiomers of Bay K 8644, the (R)-enantiomer favoring
the closed conformation and the (S)-enantiomer favoring
the open conformation. According to the calculations, the
port-down modes of nifedipine (and, possibly, other DHPs)
binding are energetically preferable to the port-up modes
(Table 2). The structural reason for this is the asymmetry of
the Ca2+ chelation at level B of the SCP (see above). In the
blocker (R)-Bay K 8644, the port-side group is the same as
in nifedipine (Fig. 8). Favorable van der Waals interaction
of this group with the bracelet of Ile-10 residues would
stabilize its pore-closing conformation (Fig. 14 a). In the
channel activator (S)-Bay K 8644, the port-side group is not
long enough to reach the bracelet (Fig. 14 b). Therefore, the
stabilization of the "wide-pore" conformation P1 would
dominate in the action of the ligand. In addition, the closed
conformation of the hydrophobic bracelet may be destabi-
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lized by unfavorable contacts with water molecules adjacent
to the activator's polar group NO2. This would explain the
intriguing paradox in the structure-activity relationships of
DHPs. There are L-type Ca2' channel activators with only
CH3 group as a port-side substituent or even without the
substituent (Goldmann and Stoltefuss, 1991). Although the
activity of such compounds at the SCP remains unknown,
this mechanism would predict them to activate SCP.
On the functional analogy between SCP and L-type
Ca2+ channels
The fact that the SCP composed of the four IVS3 segments
of the L-type channel resembles the latter in its electro-
physiological and pharmacological properties implies that
the S3 segments may contribute to the pore lining (Grove et
al., 1993). On the other hand, the pore of the voltage-gated
ionic channels was postulated to be lined up by the short
segments SS1-SS2 incorporating highly conserved residues
(Guy and Conti, 1990), and subsequent experiments proved
this prediction. For example, the mutation (K1422E) in the
SS1-SS2 region of the sodium channel conferred on it
certain properties of the Ca2+ channel (Heinemann et al.,
1992). Site-directed mutations in the SS1-SS2 region of the
L-type channel revealed four glutamate residues contribut-
ing to Ca2+ selectivity (Yang et al., 1993; Kim et al., 1993;
Mikala et al., 1993). All of this strongly suggests that the
SS1-SS2 segments line at least a part of the pore of L-type
Ca2+ channels.
Grove et al. (1993) harmonized the two lines of evidence
by suggesting that the SS1-SS2 segments are located at the
entry of the pore of the L-type Ca2+ channel and modulate
the ionic selectivity of a permeation pathway formed by a
bundle of a-helical S3 transmembrane segments. Further
experiments and molecular modeling studies are necessary
to test this suggestion. Even if the S3 segments do not
contribute to the pore of the L-type channel, the SCP may be
considered as a model Ca2+ channel whose relatively sim-
ple and unambiguous chemical structure may help us to
understand the basic principles of the ion selectivity and
pharmacological sensitivity of the Ca2+ channels. There-
fore, it is worthwhile to discuss some of the elementary
properties of the L-type Ca2+ channel in view of the struc-
tural model of the SCP.
In the absence of the experimental data on the 3-D
structure of the L-type Ca2+ channel, electrophysiological
experiments are accounted for by phenomenological models
that postulate a number of the binding sites for Ca2+ inside
the pore, the distance between the sites, affinity of the sites
for Ca2+, etc. (see Tsien at al., 1987, for a review). The
fundamental property of the authentic Ca2+ channels is their
high selectivity for Ca2+ ions with millimolar Ca2+ in the
bulk solution and a large permeability for monovalent cat-
ions when the concentration of divalent cations in the bulk
solution is below the micromolar level (Kostyuk et al.,
1983; Almers et al., 1984; Hess and Tsien, 1984). Intrigu-
micromolar Ca2+, implying the presence of a high-affinity
binding site for Ca2 , whereas the observed Ca2+ current
(0.1-1 pA) implies millimolar affinities for Ca2+ binding
sites at the permeation pathway. Similar properties were
demonstrated for the SCP (Grove et al., 1991, 1993). The
above paradox was accounted for by two different models.
Almers and McCleskey (1984) and Hess and Tsien (1984)
postulated the presence of at least two high-affinity binding
sites for Ca2' inside the pore; at the micromolar Ca2+ in the
bulk solution, one Ca2+ ion would occupy the first site
"guarding" the pore from the monovalent cations; at milli-
molar Ca2+ in the bulk solution, both sites would be occu-
pied by Ca2+ ions, their repulsion decreasing the apparent
affinity for the binding sites to the millimolar range. An
alternative model was proposed by Kostyuk et al. (1983).
The authors postulated that Ca2+ channels exist in two
different conformations, one selective for monovalent cat-
ions, the other for divalent cations; the occupation of a
regulatory high-affinity Ca2+ site outside the pore would
induce the conformational change. The latter phenomeno-
logical model may account for the same experiments, which
back the multi-ion model (Mironov, 1992).
Our structural model of SCP explicitly presents the multi-
ion pore. However, the mechanism of Ca2+ selectivity does
not exactly correspond to the mechanism postulated for the
multi-ion authentic Ca2+ channels. In the SCP, the neigh-
boring Ca2+ binding sites are not extended along the pore.
They are at the same levels normal to the pore axis. At low
Ca2+ concentration in the bulk solution, one high-affinity
complex would be formed between Ca2+ and two Glu-22
residues. The remaining two Glu-22 residues would also
contribute to the energy of Ca2+ binding by long-range
electrostatic interactions. This would explain the experi-
mentally observed blockade of Na+ current through SCP by
micromolar Ca2+ (Grove et al., 1991). At millimolar Ca2 ,
two salt bridges would be formed at the level of Glu-22. The
dipole-dipole repulsion between the two salt bridges would
decrease the affinity of Ca2+ ions to both of the sites,
allowing fast permeation of Ca2+ ions through the pore.
Similar events would occur at the levels of Asp-17 and
Asp-7 residues, although the less flexible side chains of the
Asp residues would provide a less perfect coordination of
Ca2+ in comparison to Glu residues.
Both authentic and synthetic Ca2+ channels are similarly
affected by DHPs and other ligands (Kokubun et al., 1986;
Grove et al., 1991). Our calculations demonstrate that the
asymmetry of the disposition of the Asp-17 residues relative
to the pore axis is the main reason for the energy variation
of different modes of DHP ligand binding and may account
for the different effects of enantiomers of Bay K 8644.
Interestingly, mutation experiments on L-type Ca2+ chan-
nels also reveal the functional asymmetry of the four Glu
residues around the central pore (Yang et al., 1993; Kim et
al., 1993; Mikala et al., 1993).
Recent experiments by Kuo and Hess (1993a,b) have
presented new evidence for the multi-ion model of the Ca2+
channel. The authors postulated the presence of at least
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three sets of the binding site for Ca2 , including two closely
spaced high-affinity sites. This agrees with our model.
However, such arguments cannot prove that the S3 seg-
ments contribute to the pore lining in the L-type Ca2+
channel.
In summary, our results rationalize the Ca2+ selectivity of
the SCP and its pharmacological sensitivity and account for
the paradoxical fact that (R)- and (S)-enantiomers of Bay K
8644 have opposite effects on the probability of the channel
open state. They demonstrate the crucial role of Ca2+ in the
stabilization of the structure of SCP and DHP ligand bind-
ing. The amino acid sequences of the pore-forming elements
of the authentic and synthetic Ca2+ channels are most
probably different. However, the peculiarities of their 3-D
structures relevant to Ca2+ permeation and DHP binding
may be similar. Ca2+ ions would also function as the
structure-forming elements of the L-type channel pore.
DHP ligands would also form the ternary complex with
Ca2+ inside the L-channel pore modulating the stability of
the closed conformation of the adjacent hydrophobic gate
(more precisely, those elements of the much more complex
gate mechanism of the L-type channel, which regulate the
lumen of the pore). Blockers such as (R)-Bay K 8644 would
increase the stability, whereas activators such as (S)-Bay K
8644 would decrease it. A model of the DHP receptor of the
L-type channel proposed earlier based on the considerations
of conformation-activity relationships of only ligands and
their complexes with Ca2+ also explained structure-activity
relationships of different drugs as a consequence of their
ternary association with Ca2+ inside the channel pore
(Govyrin and Zhorov, 1994). The relatively simple structure
of SCP provides several possibilities to experimentally test
the model elaborated in the present work.
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Note added in proof. In a recent study, Labarca et al. (1995) have reported
the results of mutation experiments on the nicotinic acetylcholine receptor
(nAChR) which show that channel gating is governed symmetrically and
independently by the five conserved Leu-9 residues near the midpoint of
the M2 transmembrane domain. In AchR and homologous receptors, these
Leu residues occupy a "kink" in each of the five M2 helices and point
toward the pore in the closed state of the channel. Channel opening causes
the helices to rotate so that the Leu residues do not occlude the ion
conduction pathway. Mutation of each Leu-9 by Ser in nAChR shifted the
dose-response curve of the receptor to the left by - 10-fold, suggesting that
contacts involving each of the five Leu residues play an important role in
gating. The 10-fold difference translated to a free energy contribution per
contact of - 1.4 kcal mol-'. These observations are remarkably similar to
our data on the Ile-gated channel in SCP and lend support to the usefulness
of simple model systems.
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